Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma
, , , , und
05. Sept. 2025
Über diesen Artikel
Online veröffentlicht: 05. Sept. 2025
Seitenbereich: 403 - 411
Eingereicht: 15. Juni 2025
Akzeptiert: 19. Juli 2025
DOI: https://doi.org/10.2478/raon-2025-0049
Schlüsselwörter
© 2025 Matic Setina et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Setina, Matic
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Setina, Eva
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Doljak, Ziga
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Goricar, Katja
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Dolzan, Vita
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Kovac, Viljem
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Institute of Oncology LjubljanaLjubljana, Slovenia